RecruitingNot applicableNCT05139797
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
Studying Wild type ATTR amyloidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cedars-Sinai Medical Center
- Intervention
- EchoNet-LVH screening for cardiac amyloidosis(other)
- Enrollment
- 300 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Cedars-Sinai Medical Centre (Los Angeles), Los Angeles, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05139797 on ClinicalTrials.govOther trials for Wild type ATTR amyloidosis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07238426ATTRACT-52: Primary Care Cardiac Amyloidosis Screening in Ordu, TurkeyKotyora Family Medicine Health Management and Education Association
- RECRUITINGNCT06836011A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.Medical University of Vienna
- RECRUITINGNANCT05098665PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathYRichmond Research Institute
- ENROLLING BY INVITATIONNANCT06664866AI Echocardiographic Screening of Cardiac AmyloidosisCedars-Sinai Medical Center
- RECRUITINGNCT06427304Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart FailureGérond'if
- RECRUITINGNCT06799273MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac AmyloidosisCentro Cardiologico Monzino
- ENROLLING BY INVITATIONPHASE4NCT05019027N-of-1 for Beta-Blockers in Cardiac AmyloidosisWeill Medical College of Cornell University
- ENROLLING BY INVITATIONNANCT06412432Exercise Training and Rehabilitation In Cardiac AmyloidosisFederico II University